Alexi Bueno Soler is a Chemical Engineer who has worked in the R&D BioProcess Development Department at the Center of Molecular Immunology in Havana since 2010. Alexi focuses on the development of fermentation processes at a scale of 2 and 30 liters, and the quantification of monoclonal antibodies by ELISA.
Regulatory authorities have approved the use of recombinant monoclonal antibodies (mAbs) to treat infectious diseases1
and chronic conditions such as cancer
1Sparrow, E., M. Friede, M. Sheikh, and S. Torvaldsen. “Therapeutic Antibodies for Infectious Diseases.” Bulletin of the World Health Organization 95, no. 3 (2017):235–237. doi:10.2471/BLT.16.178061